ICON plc
↗Dublin, Ireland
ICON plc is a world-leading healthcare intelligence and clinical research organization (CRO). Headquartered in Dublin, Ireland, the company provides a comprehensive range of outsourced development and commercialization services to the pharmaceutical, biotechnology, medical device, and government and public health sectors. ICON's services span the entire product lifecycle, from early-phase clinical trials to post-market surveillance and commercialization.
Following its landmark $12 billion acquisition of PRA Health Sciences in 2021, ICON has solidified its position as one of the top three global CROs. The company is known for its advanced technological platforms, such as the ICONIX platform for trial design and monitoring, and its extensive global site network. ICON operates in over 55 countries with a significant presence in emerging markets and major pharmaceutical hubs.
CLASSIFICATION
SIZE & FINANCIALS
Employees:10000+
Revenue:$8.28B
Founded:1990
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:Publicly traded
STOCK
Exchange:NASDAQ
Ticker:ICLR
Market Cap:$14.9B
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, mAb, Cell therapy, Gene therapy, Biosimilars, Medical Devices
Active Trials:2500
Trial Phases:Phase 1: 500 | Phase 2: 800 | Phase 3: 1000 | Phase 4: 200
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:PRA Health Sciences, KCR, HumanFirst, Philips Pharma Solutions, Mapi Group
Key Partnerships:Pfizer (Strategic clinical development partner), BioNTech, Lilly, Merck, Mural Health (Site experience enhancement)
COMPETITION
Position:Leader
Competitors:IQVIA, PPD (Thermo Fisher Scientific), Fortrea (Labcorp), Syneos Health, Medpace
LEADERSHIP
Key Executives:
Barry Balfe - CEO
Nigel Clerkin - CFO
Scientific Founders:Dr. John Climax, Dr. Ronan Lambe
Board Members:Ciaran Murray (Chairman), Linda Grais, Ronan Murphy, John Climax
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with ICON plc. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.